Side-by-side comparison of AI visibility scores, market position, and capabilities
Global financial data platform with $2.19B FY2024 revenue; 216,000 users; open API vs. Bloomberg's closed ecosystem; LiquidityBook OMS/EMS acquisition; AI research tools expansion.
FactSet Research Systems is a leading global financial data and portfolio analytics platform founded in 1978 by Howard Wille and Charles Snyder, headquartered in Norwalk, Connecticut and trading on Nasdaq (FDS). The company reported $2.19 billion in revenues for fiscal year 2024 (ending August 31), serving approximately 8,200 clients and 216,000 individual users across asset management, investment banking, hedge funds, private equity, and wealth management. FactSet's open, flexible platform integrates proprietary financial data with third-party content providers, enabling portfolio analytics, research workflow, and client reporting for buy-side and sell-side professionals worldwide.
Richmond VA tobacco and nicotine (NYSE: MO) ~$9.7B net revenue FY2024; Marlboro 40%+ US cigarette share, on! oral pouch competing with Zyn, 50%+ operating margins, ABI stake, competing with Reynolds/BAT.
Altria Group, Inc. is a Richmond, Virginia-based tobacco and nicotine company — publicly traded on the New York Stock Exchange (NYSE: MO) as an S&P 500 Consumer Staples component — manufacturing and selling cigarettes (Marlboro — the best-selling cigarette brand in the United States), smokeless tobacco (Copenhagen, Skoal, Red Seal, Husky chewing tobacco/moist snuff brands), oral nicotine pouches (on! brand), and maintaining a 10.7% ownership stake in Anheuser-Busch InBev (SABMiller acquisition consideration shares) and a 35% stake in JUUL Labs (vaping — original $12.8B investment written down to minimal value following JUUL's regulatory and litigation difficulties) through approximately 5,500 employees. In fiscal year 2024, Altria reported revenues of approximately $20.6 billion (net revenues after excise taxes approximately $9.7 billion), with the cigarette segment (Marlboro generating 40%+ US cigarette market share) contributing the majority of operating income at 50%+ adjusted operating margins — the highest margins in the consumer staples sector reflecting cigarettes' inelastic demand and regulated market structure. CEO Billy Gifford has pivoted Altria's strategy from cigarettes toward smoke-free nicotine products: the on! oral nicotine pouch (acquired full ownership of Helix Innovations in 2023, rebranding as on! to compete with Swedish Match Zyn, the dominant US oral nicotine pouch brand) represents Altria's primary nicotine product diversification vehicle as cigarette volume declines 7-8% annually through consumer quit rates and secular health awareness trends.
Monitor how your brand performs across ChatGPT, Gemini, Perplexity, Claude, and Grok daily.